City National Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$193M Buy
1,964,035
+64,278
+3% +$7.14M 1.66% 2
2015
Q2
$222M Sell
1,899,757
-41,394
-2% -$4.52M 1.83% 2
2015
Q1
$190M Buy
1,941,151
+48,563
+3% +$4.93M 1.61% 3
2014
Q4
$178M Buy
1,892,588
+64,770
+4% +$6.7M 1.55% 3
2014
Q3
$195M Sell
1,827,818
-18,132
-1% -$1.78M 1.78% 3
2014
Q2
$153M Buy
1,845,950
+727,987
+65% +$56.7M 1.4% 4
2014
Q1
$79.2M Buy
1,117,963
+63,559
+6% +$4.98M 1.11% 10
2013
Q4
$79.2M Buy
1,054,404
+99,408
+10% +$6.92M 1.19% 7
2013
Q3
$60M Buy
954,996
+41,358
+5% +$2.47M 1.06% 8
2013
Q2
$46.8M Buy
+913,638
New +$47.6M 0.87% 17

Other funds holding GILD

City National Bank's GILD Position: Q3 2015 in Review

City National Bank increased its Gilead Sciences (GILD) stake by 3.4% in Q3 2015, buying an estimated $7.14M and bringing the position to 1,964,035 shares worth $193M. The position accounts for 1.66% of the portfolio, ranked #2.

City National Bank first reported a position in GILD in Q2 2013 and has held it in 10 quarters since. The position peaked at $222M in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • City National Bank held 1,964,035 shares of Gilead Sciences worth $193M as of Q3 2015.
  • City National Bank bought 64,278 Gilead Sciences shares in Q3 2015, an estimated $7.14M.
  • Gilead Sciences made up 1.66% of City National Bank's portfolio in Q3 2015, its #2 holding.
  • City National Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 10 quarters since.
  • City National Bank's Gilead Sciences position peaked at $222M in Q2 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.